Not Medicare Enrolled

Dr. Martin Menter, MD

Dermatology · Dallas, TX
Speaking/Promotional
3900 JUNIUS ST, Dallas, TX 75246
9723867546
In practice since 2006 (19 years)
NPI: 1043268907 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Menter from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Menter? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Menter

Dr. Martin Menter is a dermatology in Dallas, TX, with 19 years in practice.

Between the years covered by Open Payments, Dr. Menter received a total of $796,058 from 46 pharmaceutical and/or device companies across 1226 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Menter is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice$ $796,058 industry payments

Industry Payment Transparency

Open Payments through 2023 ↗
$796,058
Total received (2018-2023)
Avg $132,676/year across 6 years
Top 1% in TX for dermatology
46
Companies
1,226
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$669,125 (84.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$122,935 (15.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,998 (0.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2023
$36
2022
$35,668
2021
$112,463
2020
$87,590
2019
$275,846
2018
$284,455

Payments by company (2023)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$173,858
Janssen Scientific Affairs, LLC
$114,787
AbbVie, Inc.
$106,712
Novartis Pharmaceuticals Corporation
$63,504
Sun Pharmaceutical Industries Inc.
$60,892
Ortho Dermatologics, a division of Bausch Health US, LLC
$48,245
Celgene Corporation
$41,388
UCB, Inc.
$29,377
Amgen Inc.
$29,049
AbbVie Inc.
$27,700
Janssen Biotech, Inc.
$26,370
Eli Lilly and Company
$22,131
Boehringer Ingelheim Pharmaceuticals, Inc.
$8,518
SUN PHARMACEUTICAL INDUSTRIES INC.
$8,492
Novartis Pharma AG
$7,725
Mindera Corp
$6,825
Clarify Medical, Inc.
$5,304
UCB SA
$4,000
MAYNE PHARMA INC.
$3,084
ABBVIE INC.
$2,600
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,400
E.R. Squibb & Sons, L.L.C.
$1,267
LEO Pharma Inc.
$539
Encore Dermatology Inc.
$300
NOVARTIS PHARMACEUTICALS CORPORATION
$283
Regeneron Healthcare Solutions, Inc.
$259
GENZYME CORPORATION
$191
Mayne Pharma Inc.
$190
Merz North America, Inc.
$178
Incyte Corporation
$139
PFIZER INC.
$120
EPI Health, LLC
$89
Promius Pharma LLC
$88
DUSA Pharmaceuticals, Inc.
$77
Allergan, Inc.
$76
Merck Sharp & Dohme Corporation
$46
Biofrontera Inc.
$37
Galderma Laboratories, L.P.
$37
Genentech USA, Inc.
$28
Tactile Systems Technology Inc
$28
SANOFI-AVENTIS U.S. LLC
$26
Allergan Inc.
$23
Pierre Fabre Pharmaceuticals, Inc.
$22
Oxford Immunotec USA Inc
$20
MEDEXUS PHARMA, INC.
$20
Mylan Pharmaceuticals Inc.
$14
Top 3 companies account for 49.7% of total payments
Associated products mentioned in payments ›
20% · ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AIN457A · ALTRENO · ARAZLO · Ameluz · BIAFINE · BLU-U · BOTOX COSMETIC · Bensal HP · CLODERM · COSENTYX · Cimzia · Clarify Home Light Therapy System · Clindamycin Phosphate and Benzoyl Peroxide · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ENSTILAR · EPIDUO FORTE · EUCRISA · Enbrel · FLEXITOUCH · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Impoyz · LEVULAN KERASTICK · LIBTAYO · Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution · Mind.PX · ODOMZO · OPZELURA · ORACEA · Otezla · Promiseb Complete · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rituxan · SILIQ · SIVEXTRO · SKYRIZI · SOOLANTRA · SORILUX · STELARA · Sernivo Spray · Sitavig · Skyrizi · TALTZ · TREMFYA · TSPOT TB TEST · Tremfya · Trianex · ULTRAVATE · XEOMIN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (84%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in dermatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for dermatology in TX.

Looking for a dermatology in Dallas?
Compare dermatologys in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse dermatologys nearby

Geographic Context

Dermatologys within 10 mi
201
Per 100K population
7.7
County median income
$74,149
Nearest hospital
BAYLOR UNIVERSITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment— Not enrolledN/A
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2023
Disciplinary History— Not publicN/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Menter is a dermatology, and high industry engagement (speaking/promotional, top 1%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Menter receive payments from pharmaceutical companies?
Yes. Dr. Menter received a total of $796,058 from 46 companies across 1,226 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Menter) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →